Publication date: Feb 13, 2025
Mapping cellular organization in the developing brain presents significant challenges due to the multidimensional nature of the data, characterized by complex spatial patterns that are difficult to interpret without high-throughput tools. Here, we present DeepCellMap, a deep-learning-assisted tool that integrates multi-scale image processing with advanced spatial and clustering statistics. This pipeline is designed to map microglial organization during normal and pathological brain development and has the potential to be adapted to any cell type. Using DeepCellMap, we capture the morphological diversity of microglia, identify strong coupling between proliferative and phagocytic phenotypes, and show that distinct spatial clusters rarely overlap as human brain development progresses. Additionally, we uncover an association between microglia and blood vessels in fetal brains exposed to maternal SARS-CoV-2. These findings offer insights into whether various microglial phenotypes form networks in the developing brain to occupy space, and in conditions involving haemorrhages, whether microglia respond to, or influence changes in blood vessel integrity. DeepCellMap is available as an open-source software and is a powerful tool for extracting spatial statistics and analyzing cellular organization in large tissue sections, accommodating various imaging modalities. This platform opens new avenues for studying brain development and related pathologies.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | cell |
drug | DRUGBANK | Trestolone |
drug | DRUGBANK | Esomeprazole |
disease | MESH | hemorrhages |
disease | MESH | tumor |
drug | DRUGBANK | Coenzyme M |
disease | IDO | process |
disease | IDO | algorithm |
disease | IDO | object |
disease | MESH | Uncertainty |
disease | MESH | confusion |
pathway | REACTOME | Apoptosis |
disease | MESH | death |
drug | DRUGBANK | Flunarizine |
drug | DRUGBANK | Ademetionine |
drug | DRUGBANK | Cysteamine |
disease | MESH | COVID19 |
drug | DRUGBANK | Sulodexide |
disease | MESH | congenital abnormalities |
disease | MESH | genetic disorders |
disease | MESH | periventricular leukomalacia |
disease | MESH | infection |
drug | DRUGBANK | Aminosalicylic Acid |
drug | DRUGBANK | Formaldehyde |
drug | DRUGBANK | Ethanol |
drug | DRUGBANK | Citric Acid |
drug | DRUGBANK | Hydrogen peroxide |
drug | DRUGBANK | Alkaline Phosphatase |
drug | DRUGBANK | Phosphate ion |
drug | DRUGBANK | Sucrose |
drug | DRUGBANK | Aspartame |